| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $216.2M | — | +78.8% |
| R&D Expense | $31.3M | — | +35.8% |
| SG&A Expense | $59.7M | — | +14.6% |
| Operating Income | $5.3M | — | +109.1% |
| Interest Expense | $12.8M | — | +0.2% |
| Pre-tax Income | -$644K | — | +99.4% |
| Income Tax | -$134K | — | — |
| Net Income | -$510K | — | +99.5% |
| EPS (Basic) | $0.00 | — | +100.0% |
| EPS (Diluted) | $0.00 | — | +100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $819.9M | +3.0% | +2527.8% |
| Short-term Investments | $2.3M | +0.9% | — |
| Accounts Receivable | $90.5M | -19.3% | — |
| Current Assets | $1.01B | +1.6% | — |
| Total Assets | $1.16B | +3.3% | — |
| Current Liabilities | $143.9M | +13.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $32.9M | — | +204.9% |
| Capital Expenditures | $10.3M | — | +284.6% |
| Investing Cash Flow | -$10.3M | — | -284.6% |
| Financing Cash Flow | $824K | — | -35.9% |
| Free Cash Flow | $22.5M | — | +166.2% |
| — |
| Long-term Debt | $381.1M | +0.7% | — |
| Total Liabilities | $568.9M | +3.7% | — |
| Stockholders' Equity | $593.5M | +2.8% | +122.8% |